The value of NIPT combined with serum cell-free DNA, estriol, AFP, and b-HCG levels in the recognition of trisomy 21 and 18 in the second trimester
2023 JingLi Fu, XiaoYan Zhong, Dan Li, YunSheng Ge, XueQin Zhang, published by CEON/CEES..
Background: This study aimed to evaluate the clinical application value of noninvasive prenatal testing from DNA (NIPT) and serum screening for screening in detecting fetal trisomy 21 and 18.
Methods: As a retrospective analysis, we collected data from 1383 women (singleton pregnancy) who underwent serum screening and noninvasive prenatal testing from DNA (NIPT) in our department from May 2015 to September 2017 and calculated the diagnostic value of the two methods.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of medical biochemistry - 42(2023), 4 vom: 27. Okt., Seite 574-581 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fu, JingLi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 12.12.2023 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5937/jomb0-33027 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365750077 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365750077 | ||
| 003 | DE-627 | ||
| 005 | 20231229123550.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5937/jomb0-33027 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1227.xml |
| 035 | |a (DE-627)NLM365750077 | ||
| 035 | |a (NLM)38084244 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fu, JingLi |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The value of NIPT combined with serum cell-free DNA, estriol, AFP, and b-HCG levels in the recognition of trisomy 21 and 18 in the second trimester |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 12.12.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a 2023 JingLi Fu, XiaoYan Zhong, Dan Li, YunSheng Ge, XueQin Zhang, published by CEON/CEES. | ||
| 520 | |a Background: This study aimed to evaluate the clinical application value of noninvasive prenatal testing from DNA (NIPT) and serum screening for screening in detecting fetal trisomy 21 and 18 | ||
| 520 | |a Methods: As a retrospective analysis, we collected data from 1383 women (singleton pregnancy) who underwent serum screening and noninvasive prenatal testing from DNA (NIPT) in our department from May 2015 to September 2017 and calculated the diagnostic value of the two methods | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a noninvasive prenatal testing from DNA (NIPT) | |
| 650 | 4 | |a serum screening | |
| 650 | 4 | |a trisomy syndrome | |
| 700 | 1 | |a Zhong, XiaoYan |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Ge, YunSheng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, XueQin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical biochemistry |d 2015 |g 42(2023), 4 vom: 27. Okt., Seite 574-581 |w (DE-627)NLM270452486 |x 1452-8258 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2023 |g number:4 |g day:27 |g month:10 |g pages:574-581 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5937/jomb0-33027 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2023 |e 4 |b 27 |c 10 |h 574-581 | ||